UPDATE 2-Starboard reports 5.7 pct stake in contract research firm Parexel


May 11 Activist investor Starboard Value LP reported a 5.7 percent stake in Parexel International Corp on Thursday, saying the U.S. contract research firm's shares were "undervalued" and represented an attractive investment opportunity. There would be "significant strategic and financial buyer interest," in Parexel, Starboard said in a regulatory filing.



from Biotech News